{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:27:04Z","timestamp":1792592824319,"version":"4.5.0"},"reference-count":198,"publisher":"Informa UK Limited","issue":"9","license":[{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","award":["HL007013"],"award-info":[{"award-number":["HL007013"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Pharmacology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1080\/17512433.2024.2396121","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T05:49:10Z","timestamp":1724824150000},"page":"817-835","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":17,"title":["Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF)"],"prefix":"10.1080","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8945-0571","authenticated-orcid":false,"given":"Katyayini","family":"Aribindi","sequence":"first","affiliation":[{"name":"Division of Pulmonary, Critical Care & Sleep Medicine, University of California Davis, School of Medicine","place":["Sacramento, USA"]},{"name":"Department of Veterans Affairs Northern California Health Care System","place":["Mather, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2049-4231","authenticated-orcid":false,"given":"Gabrielle Y.","family":"Liu","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care & Sleep Medicine, University of California Davis, School of Medicine","place":["Sacramento, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5724-3300","authenticated-orcid":false,"given":"Timothy E.","family":"Albertson","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care & Sleep Medicine, University of California Davis, School of Medicine","place":["Sacramento, USA"]},{"name":"Department of Veterans Affairs Northern California Health Care System","place":["Mather, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,8,27]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.24976\/Discov.Med.202436180.3"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(17)30433-2"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00163814"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S54815"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00005"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2023.101227"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2020.08.016"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00591-2021"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.resinv.2024.02.014"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201506-1063ST"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202202-0399ST"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60405-4"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402582"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402584"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201503-0562OC"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60546-1"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2014.02.014"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1103690"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00174914"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2017.114"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200404-571OC"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00005209"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2015.04.010"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1159\/000479976"},{"issue":"3","key":"e_1_3_5_27_1","first-page":"198","article-title":"Analysis of lung function and survival in RECAP: an open-label extension study of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"31","author":"Costabel U","year":"2014","unstructured":"Costabel U, Albera C, Bradford WZ, et al. Analysis of lung function and survival in RECAP: an open-label extension study of pirfenidone in patients with idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis. 2014 Oct 20;31(3):198\u2013205.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2022-219391"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2021.106551"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2016.07.009"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1177\/1060028020964451"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2017.23.3-b.s5"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2015-000105"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-024-02861-w"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1177\/17534666241232561"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-021-01783-1"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-023-02565-3"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0057-2017"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.1040"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2021.102051"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01070-3"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2022-219391"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm-conference.2024.209.1_MeetingAbstracts.A3742"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01157-2017"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-019-1021-2"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.54268"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2016.02.001"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908681"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-023-02630-1"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01655-2018"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/resp.13647"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1177\/17534666231165912"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2023.11.035"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(16)30421-0"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002880"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2023-002008"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199910213411703"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60551-1"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/144.2.291"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.158.1.9709089"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200906-0964OC"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200709-1446OC"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201202-0314OC"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa042976"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201201-0006PP"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1002110"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200705-732OC"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201011-1874OC"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00104612"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-9-201305070-00003"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-009-9209-8"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(19)30262-0"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2020.1773790"},{"key":"e_1_3_5_74_1","unstructured":"Fibrogen announces topline results from phase 3 ZEPHYRUS-1 study of pamrevlumab for the treatment of idiopathic pulmonary fibrosis [internet]. 2023. Available from: https:\/\/investor.fibrogen.com\/news-releases\/news-release-details\/fibrogen-announces-topline-results-phase-3-zephyrus-1-study"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.8693"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.10.5537"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02328"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2010.10.013"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202401-0116OC"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(14)70232-2"},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(16)30044-3"},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00348-2020"},{"key":"e_1_3_5_83_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-023-02778-w"},{"key":"e_1_3_5_84_1","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.52.8498"},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1811737"},{"key":"e_1_3_5_86_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000029232"},{"key":"e_1_3_5_87_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201706-1301OC"},{"key":"e_1_3_5_88_1","doi-asserted-by":"publisher","DOI":"10.21037\/jtd-23-946"},{"key":"e_1_3_5_89_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00198013"},{"issue":"67","key":"e_1_3_5_90_1","first-page":"OA2585","article-title":"Safety and efficacy study of ACT001 in IPF and fILD patients","volume":"62","author":"Glaspole I","year":"2023","unstructured":"Glaspole I, Cai D, Chambers D. Safety and efficacy study of ACT001 in IPF and fILD patients. Eur Respir J. 2023;62(suppl 67):OA2585.","journal-title":"Eur Respir J"},{"key":"e_1_3_5_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2018.08.1058"},{"issue":"67","key":"e_1_3_5_92_1","first-page":"OA1423","article-title":"Late breaking abstract - safety, tolerability and antifibrotic activity of bexotegrast: phase 2a INTEGRIS-IPF study (NCT04396756)","volume":"62","author":"Wuyts WA","year":"2023","unstructured":"Wuyts WA, Valenzuela C, Jenkins G, et al. Late breaking abstract - safety, tolerability and antifibrotic activity of bexotegrast: phase 2a INTEGRIS-IPF study (NCT04396756). Eur Respir J. 2023;62(suppl 67):OA1423.","journal-title":"Eur Respir J"},{"key":"e_1_3_5_93_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202403-0636OC"},{"issue":"3","key":"e_1_3_5_94_1","first-page":"229","article-title":"Inhalation of sodium pyruvate to reduce the symptoms and severity of respiratory diseases including COVID-19, long COVID, and pulmonary fibrosis","volume":"3","author":"Lupfer CR","year":"2021","unstructured":"Lupfer CR, Nadler R, Amen R, et al. Inhalation of sodium pyruvate to reduce the symptoms and severity of respiratory diseases including COVID-19, long COVID, and pulmonary fibrosis. Eur J Respir Med. 2021;3(3):229\u2013237.","journal-title":"Eur J Respir Med"},{"key":"e_1_3_5_95_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2201737"},{"key":"e_1_3_5_96_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2008470"},{"key":"e_1_3_5_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00165-X"},{"key":"e_1_3_5_98_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm-conference.2024.209.1_MeetingAbstracts.A1056"},{"key":"e_1_3_5_99_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.5355"},{"key":"e_1_3_5_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.resinv.2023.04.008"},{"key":"e_1_3_5_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111471"},{"key":"e_1_3_5_102_1","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00074-2016"},{"key":"e_1_3_5_103_1","doi-asserted-by":"publisher","DOI":"10.1111\/resp.12920"},{"issue":"66","key":"e_1_3_5_104_1","first-page":"864","article-title":"Silencing MMP7 expression with a lung-targeted RNAi molecule limits fibrosis and preserves pulmonary function in bleomycin-injured rats","volume":"60","author":"Yuan T","year":"2022","unstructured":"Yuan T, Nicholas A, Lakomski N, et al. Silencing MMP7 expression with a lung-targeted RNAi molecule limits fibrosis and preserves pulmonary function in bleomycin-injured rats. Eur Respir J. 2022;60(suppl 66):864.","journal-title":"Eur Respir J"},{"issue":"67","key":"e_1_3_5_105_1","first-page":"PA3909","article-title":"A clinical-stage RNAi therapeutic candidate for IPF mediates durable MMP7 silencing in nonhuman primates and human lung tissue","volume":"62","author":"Yuan T","year":"2023","unstructured":"Yuan T, Klossowski S, Afrazi M, et al. A clinical-stage RNAi therapeutic candidate for IPF mediates durable MMP7 silencing in nonhuman primates and human lung tissue. Eur Respir J. 2023;62(suppl 67):PA3909.","journal-title":"Eur Respir J"},{"key":"e_1_3_5_106_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1685"},{"key":"e_1_3_5_107_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.1c01256"},{"key":"e_1_3_5_108_1","doi-asserted-by":"publisher","DOI":"10.1513\/pats.201201-005AW"},{"key":"e_1_3_5_109_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2021-001026"},{"key":"e_1_3_5_110_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm-conference.2023.207.1_MeetingAbstracts.A2785"},{"key":"e_1_3_5_111_1","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2013-0070OC"},{"key":"e_1_3_5_112_1","doi-asserted-by":"crossref","unstructured":"Kang S-U Ryou J-H Lim J-J et al. BBT-877 a potent autotaxin inhibitor in clinical development to treat idiopathic pulmonary fibrosis. A108. Pathophysiol in diffuse parenchymal lung dis. 2019;A2577\u2013A2577.","DOI":"10.1164\/ajrccm-conference.2019.199.1_MeetingAbstracts.A2577"},{"issue":"63","key":"e_1_3_5_113_1","first-page":"A1293","article-title":"Late breaking abstract - BBT-877, a potent autotaxin inhibitor in clinical development to treat idiopathic pulmonary fibrosis","volume":"54","author":"Lee G","year":"2019","unstructured":"Lee G, Kang SU, Ryou J-H, et al. Late breaking abstract - BBT-877, a potent autotaxin inhibitor in clinical development to treat idiopathic pulmonary fibrosis. Eur Respir J. 2019;54(suppl 63):A1293.","journal-title":"Eur Respir J"},{"key":"e_1_3_5_114_1","doi-asserted-by":"publisher","DOI":"10.2174\/157340810791233033"},{"key":"e_1_3_5_115_1","first-page":"A6619","volume-title":"American journal of respiratory and critical care medicine","author":"Pencek R","year":"2024","unstructured":"Pencek R, Clark A, Barnes CN, et al. Update on the safety and tolerability of Bexotegrast, a dual-selective inhibitor of integrins \u03b1v\u03b26 and \u03b1v\u03b21. Devel for idiopathic pulm fibros and primary sclerosing cholangitis. American journal of respiratory and critical care medicine. San Diego, CA: American Thoracic Society; 2024. p. A6619\u2013A6619."},{"key":"e_1_3_5_116_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-021-01863-0"},{"key":"e_1_3_5_117_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/148.4_Pt_1.955"},{"key":"e_1_3_5_118_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01708366"},{"key":"e_1_3_5_119_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.154.3.8810624"},{"key":"e_1_3_5_120_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-012-1277-6"},{"key":"e_1_3_5_121_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2200644"},{"key":"e_1_3_5_122_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.21407"},{"key":"e_1_3_5_123_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173508"},{"key":"e_1_3_5_124_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.22529"},{"key":"e_1_3_5_125_1","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112147-20220914-00758"},{"key":"e_1_3_5_126_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-19294-1"},{"key":"e_1_3_5_127_1","doi-asserted-by":"publisher","DOI":"10.1177\/2045894019881954"},{"key":"e_1_3_5_128_1","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2020.35.e48"},{"key":"e_1_3_5_129_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.01.027"},{"key":"e_1_3_5_130_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-181746"},{"key":"e_1_3_5_131_1","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202216940"},{"key":"e_1_3_5_132_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13518"},{"key":"e_1_3_5_133_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201203-0411OC"},{"key":"e_1_3_5_134_1","doi-asserted-by":"publisher","DOI":"10.1124\/pharmrev.120.000281"},{"key":"e_1_3_5_135_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.00180"},{"key":"e_1_3_5_136_1","first-page":"A1055","volume-title":"American journal of respiratory and critical care medicine","author":"Maher TM","year":"2024","unstructured":"Maher TM, Molyneaux PL, Lindmark BE, et al. Buloxibutid, a novel angiotensin II type 2 receptor agonist, stabilized and improved lung function in individuals with idiopathic pulmonary fibrosis in the 36-week phase 2 AIR trial. American journal of respiratory and critical care medicine. San Diego (CA): American Thoracic Society; 2024. p. A1055\u2013A1055."},{"key":"e_1_3_5_137_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)89457-7"},{"issue":"2","key":"e_1_3_5_138_1","first-page":"499","article-title":"Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck","volume":"151","author":"Johansson N","year":"1997","unstructured":"Johansson N, Airola K, Grenman R, et al. Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck. Am J Pathol. 1997 Aug;151(2):499\u2013508.","journal-title":"Am J Pathol"},{"key":"e_1_3_5_139_1","doi-asserted-by":"publisher","DOI":"10.5114\/wo.2016.61565"},{"key":"e_1_3_5_140_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14133263"},{"issue":"21","key":"e_1_3_5_141_1","first-page":"4882","article-title":"Regulation of collagenase-3 expression in human breast carcinomas is mediated by stromal-epithelial cell interactions","volume":"57","author":"Uria JA","year":"1997","unstructured":"Uria JA, Stahle-Backdahl M, Seiki M, et al. Regulation of collagenase-3 expression in human breast carcinomas is mediated by stromal-epithelial cell interactions. Cancer Res. 1997 Nov 1;57(21):4882\u20134888.","journal-title":"Cancer Res"},{"key":"e_1_3_5_142_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.3008"},{"key":"e_1_3_5_143_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.914017"},{"key":"e_1_3_5_144_1","doi-asserted-by":"publisher","DOI":"10.1039\/d2sc05709c"},{"key":"e_1_3_5_145_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-024-02143-0"},{"key":"e_1_3_5_146_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23010171"},{"key":"e_1_3_5_147_1","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2008-0174OC"},{"key":"e_1_3_5_148_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.06.00012106"},{"key":"e_1_3_5_149_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0226904"},{"key":"e_1_3_5_150_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.1208"},{"key":"e_1_3_5_151_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2021-001060"},{"key":"e_1_3_5_152_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2023.106539"},{"key":"e_1_3_5_153_1","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2019-0435OC"},{"key":"e_1_3_5_154_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsptsci.2c00149"},{"key":"e_1_3_5_155_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.02754"},{"key":"e_1_3_5_156_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms13078293"},{"key":"e_1_3_5_157_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.15.6642"},{"key":"e_1_3_5_158_1","first-page":"A5391","article-title":"A novel siRNA-based oligonucleotide, TRK-250, and its efficacy for treatment of idiopathic pulmonary fibrosis (IPF). C64","author":"Shibata A","year":"2019","unstructured":"Shibata A, Matsumoto T, Uchida M, et al. A novel siRNA-based oligonucleotide, TRK-250, and its efficacy for treatment of idiopathic pulmonary fibrosis (IPF). C64. Am J Respir Crit Care Med. 2019;A5391\u2013A5391.","journal-title":"Am J Respir Crit Care Med"},{"key":"e_1_3_5_159_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19082460"},{"key":"e_1_3_5_160_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.55.091902.103810"},{"key":"e_1_3_5_161_1","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2023.0014"},{"key":"e_1_3_5_162_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-022-03181-8"},{"key":"e_1_3_5_163_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24086948"},{"key":"e_1_3_5_164_1","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2009.080629"},{"key":"e_1_3_5_165_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-022-02192-6"},{"key":"e_1_3_5_166_1","doi-asserted-by":"publisher","DOI":"10.1002\/sctm.19-0037"},{"key":"e_1_3_5_167_1","doi-asserted-by":"publisher","DOI":"10.1111\/resp.12343"},{"key":"e_1_3_5_168_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2016.10.061"},{"key":"e_1_3_5_169_1","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-11-171"},{"key":"e_1_3_5_170_1","unstructured":"Ting Z. Regend therapeutics Co ltd inventor new application of REGEND001 cell autologous transfusion preparation. China; 2020."},{"key":"e_1_3_5_171_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH16-12-0904"},{"key":"e_1_3_5_172_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00165.2021"},{"key":"e_1_3_5_173_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202106-1503OC"},{"key":"e_1_3_5_174_1","doi-asserted-by":"publisher","DOI":"10.1186\/rr166"},{"issue":"3","key":"e_1_3_5_175_1","first-page":"1481","article-title":"The antifibrotic effect and mechanism of a novel tyrosine kinase inhibitor, ZSP1603, in preclinical models of pulmonary fibrosis","volume":"24","author":"Liu ZW","year":"2020","unstructured":"Liu ZW, Zhao MY, Su XL, et al. The antifibrotic effect and mechanism of a novel tyrosine kinase inhibitor, ZSP1603, in preclinical models of pulmonary fibrosis. Eur Rev Med Pharmacol Sci. 2020 Feb;24(3):1481\u20131491.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"e_1_3_5_176_1","doi-asserted-by":"publisher","DOI":"10.1080\/03008207.2018.1500558"},{"key":"e_1_3_5_177_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903476"},{"key":"e_1_3_5_178_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.10.7243"},{"key":"e_1_3_5_179_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.101826"},{"key":"e_1_3_5_180_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1302470"},{"key":"e_1_3_5_181_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63658-9"},{"key":"e_1_3_5_182_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2011.12.022"},{"key":"e_1_3_5_183_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.15-273953"},{"key":"e_1_3_5_184_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-018-0728-9"},{"key":"e_1_3_5_185_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm-conference.2022.205.1_MeetingAbstracts.A2435"},{"issue":"2","key":"e_1_3_5_186_1","first-page":"185","article-title":"The pathogenesis of bleomycin-induced pulmonary fibrosis in mice","volume":"77","author":"Adamson IY","year":"1974","unstructured":"Adamson IY, Bowden DH. The pathogenesis of bleomycin-induced pulmonary fibrosis in mice. Am J Pathol. 1974 Nov;77(2):185\u2013197.","journal-title":"Am J Pathol"},{"key":"e_1_3_5_187_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02713855"},{"key":"e_1_3_5_188_1","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-6-11"},{"key":"e_1_3_5_189_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1205948"},{"key":"e_1_3_5_190_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.17649"},{"key":"e_1_3_5_191_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13654"},{"key":"e_1_3_5_192_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22116107"},{"key":"e_1_3_5_193_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2020.111878"},{"key":"e_1_3_5_194_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2005.03.069"},{"key":"e_1_3_5_195_1","doi-asserted-by":"publisher","DOI":"10.14715\/cmb\/2020.66.3.12"},{"issue":"61","key":"e_1_3_5_196_1","first-page":"A881","article-title":"Late breaking abstract - ND-L02-s0201 treatment leads to efficacy in preclinical IPF models","volume":"50","author":"Zabludoff S","year":"2017","unstructured":"Zabludoff S, Liu Y, Liu J, et al. Late breaking abstract - ND-L02-s0201 treatment leads to efficacy in preclinical IPF models. Eur Respir J. 2017;50(suppl 61):A881.","journal-title":"Eur Respir J"},{"key":"e_1_3_5_197_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-386471-0.00009-2"},{"key":"e_1_3_5_198_1","unstructured":"Results from phase 2 clinical trial of ND-L02-s0201 for the treatment of idiopathic pulmonary fibrosis [internet]. Nitto; 2023. Available from: https:\/\/www.nitto.com\/us\/en\/press\/2023\/0915.jsp"},{"key":"e_1_3_5_199_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00149614"},{"key":"e_1_3_5_200_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202312-2213SO"}],"container-title":["Expert Review of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17512433.2024.2396121","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T08:38:37Z","timestamp":1738831117000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17512433.2024.2396121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,27]]},"references-count":198,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["10.1080\/17512433.2024.2396121"],"URL":"https:\/\/doi.org\/10.1080\/17512433.2024.2396121","relation":{},"ISSN":["1751-2433","1751-2441"],"issn-type":[{"value":"1751-2433","type":"print"},{"value":"1751-2441","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,27]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-05-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}